Clear cell adenocarcinoma of the male urethra: clinical case report
نویسندگان
چکیده
منابع مشابه
Cytologic Findings of Clear Cell Adenocarcinoma of the Urethra: A Case Report
Clear cell adenocarcinoma of the urethra is a rare disease entity with an uncertain histogenesis. Here, we present a case of primary clear cell adenocarcinoma of the female urethra with its cytological findings. A 54-year-old woman presented with a painless gross hematuria lasting 3 months. On vaginal sonography, there was a sausage-like, elongated mass in the urethra, measuring 3.8×4.3 cm. The...
متن کاملClear Cell Adenocarcinoma of the Urethra: Review of the Literature
BACKGROUND Clear cell adenocarcinoma of the urethra (CCAU) is extremely rare and a number of clinicians may be unfamiliar with its diagnosis and biological behaviour. AIMS To review the literature on CCAU. METHODS Various internet databases were used. RESULTS/LITERATURE REVIEW (i) CCAU occurs in adults and in women in the great majority of cases. (ii) It has a particular association with ...
متن کاملClear Cell Adenocarcinoma of the Female Urethra, Mimicking Cystocele
Clear cell adenocarcinoma of the urethra is an extremely rare neoplasm mainly described in women. Anterior pelvic exenteration was the treatment performed in most reported cases. It seems to have poorer prognosis than urothelial carcinomas.
متن کاملAdenocarcinoma of the female urethra: Clear-cell variant
Primary urethral carcinoma is a rare malignancy with an annual age-adjusted incidence rate of 1.5 per million in females in the U.S. The three main histologic subtypes include transitional-cell carcinoma, squamous-cell carcinoma, and adenocarcinoma. Of these, adenocarcinoma is the least common. Female urethral carcinomas are aggressive neoplasms with a generally poor prognosis. We report a case...
متن کاملHigh-dose-rate brachytherapy – a novel treatment approach for primary clear cell adenocarcinoma of male urethra
The incidence of male urethral cancer is rare with age preponderance of 50 to 60 years. The standard management approach is surgery. Here, we present a novel treatment approach for male urethral cancer. Thirty-six year old male, case of primary clear cell adenocarcinoma of urethra who refused surgery, underwent cystoscopic assisted intraluminal HDR brachytherapy. Patient received a dose of 36 G...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Brazilian Journal of Oncology
سال: 2021
ISSN: 1806-6054
DOI: 10.5935/2526-8732.20210007